Insights

Innovative Biomarkers MiraDx has developed a unique class of genetic biomarkers based on microRNA biology that are proven to enhance personalized cancer treatment, opening opportunities for partnerships in precision diagnostics and targeted therapies.

Recent Product Launch The company recently launched the PROSTOX ultra test for predicting radiation therapy side effects in prostate cancer, indicating a growing product portfolio ready for market expansion and targeted sales efforts in radiation oncology.

Strategic Collaborations MiraDx actively collaborates with academic institutions like UCLA and industry partners, demonstrating open channels for joint ventures, licensing agreements, and co-development opportunities in molecular diagnostics.

Market Validation Multiple peer-reviewed studies validating the predictive power of MiraDx's biomarkers and tests provide credibility and an evidentiary basis for engaging with healthcare providers and insurance payers for wider adoption.

Growth Potential With a revenue range of up to $10 million and expanding product offerings, MiraDx presents a promising partnership prospect for investors and service providers aiming to tap into personalized oncology diagnostics.

MiraDx, Inc. Tech Stack

MiraDx, Inc. uses 8 technology products and services including oEmbed, Google Workspace, Google Fonts API, and more. Explore MiraDx, Inc.'s tech stack below.

  • oEmbed
    Dev Tools
  • Google Workspace
    Email
  • Google Fonts API
    Font Scripts
  • Google Cloud
    Infrastructure As A Service
  • JSON-LD
    Javascript Frameworks
  • imagesLoaded
    Javascript Libraries
  • WP Engine
    Platform As A Service
  • Facebook
    Widgets

Media & News

MiraDx, Inc.'s Email Address Formats

MiraDx, Inc. uses at least 1 format(s):
MiraDx, Inc. Email FormatsExamplePercentage
First@miradx.comJohn@miradx.com
46%
FLast@miradx.comJDoe@miradx.com
4%
First@miradx.comJohn@miradx.com
46%
FLast@miradx.comJDoe@miradx.com
4%

Frequently Asked Questions

Where is MiraDx, Inc.'s headquarters located?

Minus sign iconPlus sign icon
MiraDx, Inc.'s main headquarters is located at 11601 Wilshire Boulevard 105 Los Angeles, California United States. The company has employees across 1 continents, including North America.

What is MiraDx, Inc.'s phone number?

Minus sign iconPlus sign icon
You can contact MiraDx, Inc.'s main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is MiraDx, Inc.'s stock symbol?

Minus sign iconPlus sign icon
MiraDx, Inc. is a publicly traded company; the company's stock symbol is LMDXW.

What is MiraDx, Inc.'s official website and social media links?

Minus sign iconPlus sign icon
MiraDx, Inc.'s official website is miradx.com and has social profiles on LinkedIn.

What is MiraDx, Inc.'s SIC code NAICS code?

Minus sign iconPlus sign icon
MiraDx, Inc.'s SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does MiraDx, Inc. have currently?

Minus sign iconPlus sign icon
As of February 2026, MiraDx, Inc. has approximately 27 employees across 1 continents, including North America. Key team members include Chief Operating Officer: B. M.Vp Of Engineering: T. M.Owner: M. P.. Explore MiraDx, Inc.'s employee directory with LeadIQ.

What industry does MiraDx, Inc. belong to?

Minus sign iconPlus sign icon
MiraDx, Inc. operates in the Biotechnology Research industry.

What technology does MiraDx, Inc. use?

Minus sign iconPlus sign icon
MiraDx, Inc.'s tech stack includes oEmbedGoogle WorkspaceGoogle Fonts APIGoogle CloudJSON-LDimagesLoadedWP EngineFacebook.

What is MiraDx, Inc.'s email format?

Minus sign iconPlus sign icon
MiraDx, Inc.'s email format typically follows the pattern of First@miradx.com. Find more MiraDx, Inc. email formats with LeadIQ.

When was MiraDx, Inc. founded?

Minus sign iconPlus sign icon
MiraDx, Inc. was founded in 2010.

MiraDx, Inc.

Biotechnology ResearchCalifornia, United States11-50 Employees

MiraDX was founded by Joanne Weidhaas, M.D., Ph.D. and Frank Slack, Ph.D., whose cutting-edge genetic research has unveiled a new class of genetic biomarkers, based on microRNA biology. Our mission is to apply these novel biomarkers to improve personalized cancer treatment. 
 
We have been applying these biomarkers to better direct cancer treatments, including radiation, chemotherapy, and newly developing immune therapies. We are able to apply our biomarkers to the daunting problem of toxicity from treatment, which no other set of biomarkers has been able to do.  

Through worldwide collaborations MiraDX has advanced this class of biomarkers to the forefront of personalized therapy, and has numerous collaborations across both academic and industry. We encourage you to learn more by visiting our website at MiraDX.com, as well as through visiting our sister non-profit, MiraKind, at MiraKind.org.

Section iconCompany Overview

Headquarters
11601 Wilshire Boulevard 105 Los Angeles, California United States
Phone number
Website
miradx.com
SIC Code
8733 - Noncommercial Research Organizations
Stock Symbol
LMDXW
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2010
Employees
11-50

Section iconFunding & Financials

  • $1M$10M

    MiraDx, Inc.'s revenue is estimated to be in the range of $1M$10M

Section iconFunding & Financials

  • $1M$10M

    MiraDx, Inc.'s revenue is estimated to be in the range of $1M$10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.